Roberto Falotico, MD

Commentary

Preventing Restenosis with Stent Drug Coatings

08/01/2008

Kirk N. Garratt , MD, MSc;

Tim A. Fischell , MD, FACC, FSCAI;

Jorge A. Belardi , MD, PhD;

Christopher U. Cates , MD;

Philip Walker , MD;

Roberto Falotico , MD;

Uncertainties with Drug-Eluting Stents Percutaneous coronary revascularization is a worldwide accepted technique as part of the treatment of coronary artery disease. Despite the use of stents, restenosis continues to be the major limitation...

Uncertainties with Drug-Eluting...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Roberto Falotico, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products